SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535610-22-000015
Filing Date
2022-01-04
Accepted
2022-01-03 19:32:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G-A LIXT 1.03.22 lixt0122.txt SC 13G/A 11566
  Complete submission text file 0001535610-22-000015.txt   13195
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Subject) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81115 | Film No.: 22503543
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A